Address larger ethical implications of medical treatment of ADHD by the mental health professional

What can be done, if anything, to control the federal bureaucracy?
November 28, 2020
Find the Stackelberg leader quantity in this game.
November 28, 2020

Assignment: Addressing Ethical Implications in the Treatment of ADHD

Generally, mental health professionals attempt to empower clients to care for their own problems by supporting client agency. However, in some cases clients may be stifled in their efforts to self-advocate. In other instances, clients may make dangerous, potentially lethal decisions out of misinformation or attempts to get high. Mental health professionals should be prepared to identify warning signs that might indicate a need to protect a client beyond asking that she or he take the necessary steps.

For this Assignment, review the ADHD case study of “Junior” in the Learning Resources. Consider the ethical implications of the client’s presentation as well as the role of the mental health professional in treating this client. Plan steps to begin treatment of this client’s condition.

In a 2- to 3-page, APA-formatted paper, include the following Support your explanations with scholarly evidence and information from the DSM-5.

An explanation of what may be occurring in this case.

An explanation of the psychopharmacological interventions a mental health professional might recommend to treat this client and why these interventions might be necessary.

Address ethical implications that may be present in the client’s presentation

Address larger ethical implications of medical treatment of ADHD by the mental health professional

Support your explanations with scholarly evidence and information from the DSM-5.

Resources

Lichtblau, L. (2011). Psychopharmacology demystified. Clifton Park, NY: Delmar, Cengage Learning.

Chapter 5, “Cognitive Enhancers” (pp. 65–74)

Preston, J. D., O’Neal, J. H., & Talaga, M. C. (2017). Handbook of clinical psychopharmacology for therapists (8th ed.). Oakland, CA: New Harbinger.

Chapter 23, “Child and Adolescent Psychopharmacology” (pp. 255-276)

trbet giriş - Olivenöl -

lavivabet giriş